Go Pro

Tactile Systems Technology (TCMD) Competitors

Tactile Systems Technology logo
$23.58 +0.22 (+0.94%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$23.58 +0.01 (+0.02%)
As of 08/25/2026 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TCMD vs. NVCR, LMAT, INSP, KMTS, and CNMD

Should you buy Tactile Systems Technology stock or one of its competitors? Tactile Systems Technology's main competitors and comparable companies include NovoCure (NVCR), LeMaitre Vascular (LMAT), Inspire Medical Systems (INSP), Kestra Medical Technologies (KMTS), and CONMED (CNMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Tactile Systems Technology compare to NovoCure?

Tactile Systems Technology (NASDAQ:TCMD) and NovoCure (NASDAQ:NVCR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market.

Tactile Systems Technology currently has a consensus target price of $38.40, indicating a potential upside of 62.85%. NovoCure has a consensus target price of $21.20, indicating a potential upside of 20.32%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, equities analysts plainly believe Tactile Systems Technology is more favorable than NovoCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
NovoCure
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

Tactile Systems Technology has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$329.52M1.62$19.09M$1.0821.83
NovoCure$655.35M3.13-$136.23M-$1.30N/A

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by insiders. Comparatively, 6.6% of NovoCure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Tactile Systems Technology had 3 more articles in the media than NovoCure. MarketBeat recorded 5 mentions for Tactile Systems Technology and 2 mentions for NovoCure. Tactile Systems Technology's average media sentiment score of 1.67 beat NovoCure's score of 1.08 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
NovoCure
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tactile Systems Technology has a net margin of 7.10% compared to NovoCure's net margin of -21.25%. Tactile Systems Technology's return on equity of 11.49% beat NovoCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology7.10% 11.49% 9.17%
NovoCure -21.25%-44.00%-15.85%

Summary

Tactile Systems Technology beats NovoCure on 11 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

LeMaitre Vascular has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

LeMaitre Vascular has higher earnings, but lower revenue than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$249.60M7.24$57.73M$2.8527.71
Tactile Systems Technology$329.52M1.62$19.09M$1.0821.83

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, LeMaitre Vascular had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for LeMaitre Vascular and 5 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 1.67 beat LeMaitre Vascular's score of 1.39 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Tactile Systems Technology
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

LeMaitre Vascular has a net margin of 25.02% compared to Tactile Systems Technology's net margin of 7.10%. LeMaitre Vascular's return on equity of 15.63% beat Tactile Systems Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular25.02% 15.63% 10.06%
Tactile Systems Technology 7.10%11.49%9.17%

LeMaitre Vascular presently has a consensus target price of $110.60, indicating a potential upside of 40.05%. Tactile Systems Technology has a consensus target price of $38.40, indicating a potential upside of 62.85%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts clearly believe Tactile Systems Technology is more favorable than LeMaitre Vascular.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

LeMaitre Vascular beats Tactile Systems Technology on 10 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to Inspire Medical Systems?

Tactile Systems Technology (NASDAQ:TCMD) and Inspire Medical Systems (NYSE:INSP) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Inspire Medical Systems had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for Inspire Medical Systems and 5 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 1.67 beat Inspire Medical Systems' score of 1.44 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a net margin of 15.03% compared to Tactile Systems Technology's net margin of 7.10%. Tactile Systems Technology's return on equity of 11.49% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology7.10% 11.49% 9.17%
Inspire Medical Systems 15.03%8.64%7.45%

Tactile Systems Technology currently has a consensus target price of $38.40, suggesting a potential upside of 62.85%. Inspire Medical Systems has a consensus target price of $66.19, suggesting a potential upside of 8.09%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, equities research analysts plainly believe Tactile Systems Technology is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21

Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Inspire Medical Systems has higher revenue and earnings than Tactile Systems Technology. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$329.52M1.62$19.09M$1.0821.83
Inspire Medical Systems$911.98M1.94$145.42M$4.6213.25

Summary

Inspire Medical Systems beats Tactile Systems Technology on 9 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to Kestra Medical Technologies?

Tactile Systems Technology (NASDAQ:TCMD) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Tactile Systems Technology has a net margin of 7.10% compared to Kestra Medical Technologies' net margin of -138.35%. Tactile Systems Technology's return on equity of 11.49% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology7.10% 11.49% 9.17%
Kestra Medical Technologies -138.35%-57.38%-41.10%

Tactile Systems Technology currently has a consensus target price of $38.40, indicating a potential upside of 62.85%. Kestra Medical Technologies has a consensus target price of $28.14, indicating a potential upside of 4.54%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

83.4% of Tactile Systems Technology shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Tactile Systems Technology has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

Tactile Systems Technology has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$329.52M1.62$19.09M$1.0821.83
Kestra Medical Technologies$95.13M16.58-$131.61M-$2.42N/A

In the previous week, Tactile Systems Technology had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 5 mentions for Tactile Systems Technology and 2 mentions for Kestra Medical Technologies. Tactile Systems Technology's average media sentiment score of 1.67 beat Kestra Medical Technologies' score of 0.58 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kestra Medical Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Tactile Systems Technology beats Kestra Medical Technologies on 13 of the 15 factors compared between the two stocks.

How does Tactile Systems Technology compare to CONMED?

CONMED (NYSE:CNMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

CONMED has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

CONMED has higher revenue and earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.37B1.11$47.06M$1.8527.60
Tactile Systems Technology$329.52M1.62$19.09M$1.0821.83

In the previous week, Tactile Systems Technology had 1 more articles in the media than CONMED. MarketBeat recorded 5 mentions for Tactile Systems Technology and 4 mentions for CONMED. Tactile Systems Technology's average media sentiment score of 1.67 beat CONMED's score of 0.66 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Tactile Systems Technology
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

CONMED currently has a consensus target price of $41.40, indicating a potential downside of 18.93%. Tactile Systems Technology has a consensus target price of $38.40, indicating a potential upside of 62.85%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
2 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Tactile Systems Technology has a net margin of 7.10% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Tactile Systems Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED4.12% 14.31% 6.33%
Tactile Systems Technology 7.10%11.49%9.17%

83.4% of Tactile Systems Technology shares are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Tactile Systems Technology beats CONMED on 10 of the 16 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCMD vs. The Competition

MetricTactile Systems TechnologyHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$529.16M$5.95B$7.35B$12.72B
Dividend YieldN/A1.74%2.53%10.79%
P/E Ratio21.8326.05271.0124.14
Price / Sales1.6270.33636.41102.23
Price / Cash20.2833.2778.5753.12
Price / Book2.396.2713.146.25
Net Income$19.09M$149.30M$3.46B$347.86M
7 Day Performance-0.08%0.25%1.52%0.98%
1 Month Performance-14.19%9.16%8.81%5.24%
1 Year Performance81.38%6.87%26.07%17.04%

Tactile Systems Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCMD
Tactile Systems Technology
4.2118 of 5 stars
$23.58
+0.9%
$38.40
+62.8%
+81.4%$529.16M$329.52M21.831,086
NVCR
NovoCure
3.0823 of 5 stars
$17.62
+5.1%
$21.20
+20.3%
+50.6%$2.05B$655.35MN/A1,605
LMAT
LeMaitre Vascular
4.8717 of 5 stars
$78.97
-1.2%
$110.60
+40.1%
-19.1%$1.81B$262.43M27.71490
INSP
Inspire Medical Systems
3.3223 of 5 stars
$61.23
-0.4%
$66.19
+8.1%
-34.3%$1.77B$911.98M13.251,333
KMTS
Kestra Medical Technologies
1.6643 of 5 stars
$26.92
+0.0%
$28.14
+4.5%
+51.9%$1.58B$95.13MN/A300

Related Companies and Tools


This page (NASDAQ:TCMD) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners